Bcl-xL antagonist 2 is an effective and selective antagonist of Bcl-xL with an IC50 of 91 nM and a Ki of 65 nM. Bcl-xL antagonist 2 induces apoptosis in cancer cells and can be used in studies about chronic lymphocytic leukemia and non-Hodgkins lymphoma.
Molecular Weight:
436.51
Purity:
99.26%
CAS Number:
[1235032-75-3]
Formula:
C21H16N4O3S2
Target:
Bcl-2 Family|||Apoptosis
T38622
* VAT and and shipping costs not included. Errors and price changes excepted